From: Impact of skeletal muscle mass on postoperative complications in oral cancer surgery
Variable | Without AEs (n = 64) | With AEs (n = 56) | p-value |
---|---|---|---|
Age (years), median (range) | 64 (30–86) | 63 (26–80) | 0.634a |
Sex | |||
Male | 50 (78.1%) | 35 (62.5%) | 0.072b |
Female | 14 (21.9%) | 21 (37.5%) | |
Low SMI | 6 (9.4%) | 14 (25.0%) | 0.028b |
BMI (kg/m2), mean ± SD | 22.9 ± 4.1 | 21.8 ± 3.7 | 0.136a |
Low BMI < 18.5 | 9 (14.1%) | 8 (14.3%) | 1.000b |
Stage | |||
II, III | 15 (23.4%) | 15 (26.8%) | 0.679b |
IV | 49 (76.6%) | 41 (73.2%) | |
Alcohol | 35 (54.7%) | 23 (41.1%) | 0.707b |
Smoking | 33 (51.6%) | 27 (48.2%) | 0.855b |
Location | |||
Tongue | 40 (62.5%) | 29 (51.8%) | 0.150b |
Mandible | 9 (14.1%) | 17 (30.4%) | |
Buccal mucosa | 5 (7.81%) | 5 (8.93%) | |
Floor of mouth | 10 (15.6%) | 5 (8.93%) | |
Neck dissection | |||
Unilateral | 53 (82.8%) | 47 (83.9%) | 1.00b |
Bilateral | 11 (17.2%) | 9 (16.1%) | |
ASA-PS score ≥ 2 | 27 (42.1%) | 21 (37.5%) | 0.709b |
ACE-27 | |||
0–1 | 26 (40.6%) | 17 (30.4%) | 0.259b |
2–3 | 38 (59.4%) | 39 (69.6%) | |
Preoperative laboratory data, median (IQR) | |||
Leukocyte count (× 109/l) | 6.1 (5.2–8.0) | 6.2 (5.0–7.5) | 0.582a |
Platelet count (× 109/l) | 235 (202–275) | 240 (193–285) | 0.807a |
Hemoglobin (g/dl) | 14.5 (14.1–14.8) | 14.4 (14.0–14.7) | 0.356a |
Albumin (g/dl) | 4.4 (4.1–4.6) | 4.4 (4.1–5.3) | 0.513a |
C-reactive protein | 0.09 (0.05–0.28) | 0.075 (0.05–0.26) | 0.475a |
Prognostic nutritional index | 51.3 (48.4–55.3) | 52.6 (48.9–55.9) | 0.566a |
Operation time (min), median (IQR) | 783 (688–873) | 812 (668–857) | 0.816a |
Blood loss (ml), median (IQR) | 670 (420–1027) | 670 (450–950) | 0.924a |